The GAVI Alliance has launched a new set of evaluations to collect real-time data on immunisation programmes, vaccine-related issues and the contribution of Alliance support in five countries.
A Bangladeshi child is vaccinated with GAVI support.
Photo credit: GAVI/2011/Dan Thomas
The GAVI Alliance takes the need for independent evaluation of its programmes extremely seriously. Our evidence-based approach is key to helping us reach our goal of immunising an additional quarter of a billion children by 2015, averting four million future deaths.
It is vital that we understand how vaccination programmes are being implemented, what they are achieving, the obstacles to immunisation that individual countries face and the impact that GAVI support is having on the lives of children and adults.
Bangladesh, India, Mozambique, Uganda and Zambia are taking part in the Full Country Evaluation project, which will run from 2013 to 2016. Local research institutions are partnering with the Institute of Health Metrics and Evaluation and PATH to collect information, data and evidence to help improve immunisation programmes.
Results and findings from these evaluations will be made available on the GAVI website throughout the evaluation period.
Key principles of the Full Country Evaluations
First annual progress report
This report is the first annual progress report for the Full Country Evaluations project. It summarises work done in 2013 and evaluation activities to be taken forward in 2014. A report containing findings and recommendations in relation to the process evaluation of the introduction of Pneumococcal Conjugate Vaccine in Mozambique, Uganda and Zambia, along with its management response, is forthcoming.
- Real-time data – Timely and systematic feedback to country stakeholders and the GAVI Alliance for program improvement
- Country-driven approach – evaluation led by in-country researchers reflecting the needs of country partners
- Sustainability – Strengthen country capacity and create a sustainable monitoring and evaluation structure that can be used for other purposes
- Efficiency – Leverage and build upon existing monitoring and evaluation activities and avoid duplication
- Flexibility – adaptive evaluation approach
Scope and evaluation methods
The evaluations will examine factors that influence successful immunisation programmes, obstacles to strengthening them, and the contribution of the GAVI Alliance to improvements. GAVI’s support for new and underused vaccines will be assessed, along with cash-based support to countries. The scope and methods employed will vary to some extent across the five countries, but will include:
- Process evaluation methods (key informant interviews, stakeholder network analysis, process tracking, focus groups, observation etc)
- Resource tracking
- Facility and household surveys
- Vaccine effectiveness studies, including innovative methods such as the use of biomarkers
- Small-area analysis, for example, at the district level of key indicators such as immunisation coverage and child mortality
The Evaluation Coalition
Following a competitive bidding process, a coalition led by the Institute for Health Metrics and Evaluation , University of Washington was selected to conduct these evaluations in the five countries. The other members of the coalition include: